SYK · Stryker Corporation
$332.312026-07-21Sector: Healthcare; Industry: Medical - Devices; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$165
-50.4% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($151 · $169) Analysts Range ($315 · $465) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $20.5B | — | 22.8% | 14.2% | $4.0B | −$1.8B | $2.2B | 7.5% | — | 12.0% | $33.3B | $8.19 | — |
| 2024.Q4 | $20.5B | 0.0% | 22.8% | 14.3% | $4.0B | −$2.4B | $1.6B | 8.2% | — | 12.0% | $33.4B | $8.19 | — |
| 2025.Q1 | $22.6B | 10.2% | 24.5% | 14.2% | $4.7B | −$6.9B | −$2.2B | 7.9% | — | 13.0% | $39.3B | $7.74 | — |
| 2025.Q4 | $22.6B | 0.0% | 24.5% | 28.1% | $4.0B | −$4.4B | −$472MM | 8.1% | — | 10.4% | $37.1B | $7.74 | — |
| 2026.Q1 | $25.3B | 11.8% | 23.3% | 27.5% | $4.3B | $531MM | $4.8B | 7.7% | — | 11.2% | $39.2B | $8.63 | 21.8 |
| italics below = DCF projection · 10yr Rev CAGR: 7.5% |
| 2027.Q1 | $27.8B | +10.1% | 21.3% | 26.7% | $4.3B | −$4.1B | $277MM | 7.7% | $257MM | 10.5% | $43.3B | $10.29 | 32.3 |
| 2028.Q1 | $30.2B | +8.4% | 21.7% | 26.0% | $4.9B | −$3.8B | $1.0B | 7.8% | $894MM | 10.7% | $47.1B | $11.50 | 28.9 |
| 2029.Q1 | $32.7B | +8.3% | 23.0% | 25.2% | $5.6B | −$4.2B | $1.4B | 7.9% | $1.1B | 11.4% | $51.3B | $13.30 | 25.0 |
| 2030.Q1 | $35.6B | +9.0% | 23.4% | 24.5% | $6.3B | −$5.0B | $1.3B | 8.0% | $954MM | 11.7% | $56.3B | $14.92 | 22.3 |
| 2031.Q1 | $38.8B | +8.8% | 23.4% | 23.7% | $6.9B | −$5.5B | $1.4B | 8.1% | $959MM | 11.7% | $61.9B | $16.40 | 20.3 |
|
| Term. Yr+ | $54.0B | 4.1% | 19.6% | 20.0% | $8.5B | −$2.6B | $5.8B | 8.6% | $59.3B | 13.1% | — | — | — |
Active scenario IV: $165 (-50.4% vs market)